Buledoktor ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  2.6% 2.6% 2.6% 2.6% 2.6%  
Bankruptcy risk  0.0% 0.0% 0.0% 15.3% 18.8%  
Credit score (0-100)  0 0 0 12 6  
Credit rating  N/A N/A N/A BB B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 -1.9 278  
EBITDA  0.0 0.0 0.0 -1.9 -509  
EBIT  0.0 0.0 0.0 -1.9 -572  
Pre-tax profit (PTP)  0.0 0.0 0.0 -1.9 -568.7  
Net earnings  0.0 0.0 0.0 -1.9 -445.4  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 -1.9 -569  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 360  
Shareholders equity total  0.0 0.0 0.0 38.1 -127  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 124  
Balance sheet total (assets)  0.0 0.0 0.0 39.3 1,214  

Net Debt  0.0 0.0 0.0 0.0 -84.6  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 -1.9 278  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Employees  0 0 0 0 2  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 39 1,214  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% 2,986.7%  
Added value  0.0 0.0 0.0 -1.9 -508.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 644  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 -1.0 -2.0  

Profitability 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% 100.0% -205.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% -4.9% -82.1%  
ROI %  0.0% 0.0% 0.0% -5.0% -699.2%  
ROE %  0.0% 0.0% 0.0% -5.0% -71.2%  

Solidity 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 0.0% 0.0% 96.8% -9.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% 0.0% 16.6%  
Gearing %  0.0% 0.0% 0.0% 0.0% -97.4%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 3.3%  

Liquidity 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 0.0 31.5 0.4  
Current Ratio  0.0 0.0 0.0 31.5 0.4  
Cash and cash equivalent  0.0 0.0 0.0 0.0 208.6  

Capital use efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 38.1 -834.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 -254  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 -254  
EBIT / employee  0 0 0 0 -286  
Net earnings / employee  0 0 0 0 -223